The results showed that SchC decreased the expression levels of p-PI3K, p-Akt, and p-mTOR in the livers of chronic stress-induced dyslipidemic mice, indicating that SchC restored chronic stress-induced dyslipidemia in mice by inhibiting the PI3K/Akt/mTOR signaling pathway of autophagy injury. Here, MTOR is linked to metabolic syndrome.